Comparing the effects of fish liver oil and Boswellia Serrata with placebo on multiple sclerosis patients
Phase 2
- Conditions
- Multiple sclerosis.Multiple Sclerosis
- Registration Number
- IRCT2013020812399N1
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jondishapour University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Inclusion criteria : 1- Age between 20 and 55
2- Multiple sclerosis patients taking Interferon
4- No new emotional stress when the patients are under the study
5- No cytotoxic therapy
Exclusion criteria :
1-Younger than 20 and older than 55
2-Intake of corticosteroid pulse during study
3- New emotional stress on the patient during study
4- New multiple sclerosis attack during study
5- Cytotoxic drug during study
6- Glatiramer acetat ingestion during study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue scale. Timepoint: before intervention and one month after beginning of intervention. Method of measurement: fatigue scale of the patient of multiple sclerosis as a questionnaire.
- Secondary Outcome Measures
Name Time Method